@article{a80575df5179408e994291ec30de5d93,
title = "Mother-to-infant transmission of the carcinogenic colibactin-producing bacteria",
abstract = "Background: The Escherichia coli strain that is known to produce the genotoxic secondary metabolite colibactin is linked to colorectal oncogenesis. Therefore, understanding the properties of such colibactin-positive E. coli and the molecular mechanism of oncogenesis by colibactin may provide us with opportunities for early diagnosis or prevention of colorectal oncogenesis. While there have been major advances in the characterization of colibactin-positive E. coli and the toxin it produces, the infection route of the clb + strain remains poorly characterized. Results: We examined infants and their treatments during and post-birth periods to examine potential transmission of colibactin-positive E. coli to infants. Here, analysis of fecal samples of infants over the first month of birth for the presence of a colibactin biosynthetic gene revealed that the bacterium may be transmitted from mother to infant through intimate contacts, such as natural childbirth and breastfeeding, but not through food intake. Conclusions: Our finding suggests that transmission of colibactin-positive E. coli appears to be occurring at the very early stage of life of the newborn and hints at the possibility of developing early preventive measures against colorectal cancer.",
keywords = "Colibactin, Colorectal cancer, Escherichia coli, Natural product, Perinatal transmission",
author = "Yuta Tsunematsu and Koji Hosomi and Jun Kunisawa and Michio Sato and Noriko Shibuya and Emiko Saito and Haruka Murakami and Yuko Yoshikawa and Yuji Iwashita and Noriyuki Miyoshi and Michihiro Mutoh and Hideki Ishikawa and Haruhiko Sugimura and Motohiko Miyachi and Keiji Wakabayashi and Kenji Watanabe",
note = "Funding Information: This study was funded by the Development of Innovative Research on Cancer Therapeutics from Japan Agency for Medical Research and Development (AMED) (K.Watanabe, 16ck0106243h0001; 19ck0106475h0001), Innovative Areas from MEXT, Japan (K.Watanabe, 16H06449), the Takeda Science Foundation (K.Watanabe), the Institution of Fermentation at Osaka (K.Watanabe), the Princess Takamatsu Cancer Research Fund (K.Watanabe, 16-24825), Kobayashi Foundation for Cancer Research (K.Watanabe), the Yakult Bio-Science Foundation (K.Watanabe) and SECOM Science and Technology Foundation (K.Watanabe). The funding bodies had no role in the design of the study and collection, analysis, interpretation of data, or manuscript preparation. Publisher Copyright: {\textcopyright} 2021, The Author(s).",
year = "2021",
month = dec,
doi = "10.1186/s12866-021-02292-1",
language = "English",
volume = "21",
journal = "BMC Microbiology",
issn = "1471-2180",
publisher = "BioMed Central",
number = "1",
}